HARLEYSVILLE, Penn., May 10, 2017 /PRNewswire-iReach/ -- Design Space InPharmatics (DSI), a full-service CMC consulting firm specializing in regulatory affairs, drug development consulting services, and operations management for the life sciences industry, announced today the appointment of Rob Rigney to the position of Vice President of Business Development and Business Strategy.
“Rob’s extensive experience in CMC and regulatory drug development will be extremely valuable to our customers and supports our strategy of providing a single, integrated source for efficient problem-solving strategies and scientific expertise,” said Ed Narke, Principal and Co-Founder of DSI. “As we celebrate 10 years of excellence, we are very pleased to be adding such a highly respected and talented individual to our management team to drive our company’s continued growth and development. Rob was incredibly successful at Pharmatek and we are looking forward to Rob duplicating his achievements for DSI.”
Mr. Rigney joins DSI with over 20 years of experience in regulated drug development and pharmaceutical manufacturing. Prior to joining DSI, Rob spent nearly a decade with Pharmatek Laboratories and their successor Catalent Pharma Solutions as Director of Business Development. Earlier, Rob managed development and manufacturing operations in the laboratory, pilot, and production plants at PharmPro, a division of Fluid Air, Inc. It was at Fluid Air that Rob moved into business development. Prior to entering into the pharmaceutical industry, Rob conducted scientific research at several organizations including Michigan Molecular Institute and Argonne National Laboratory. He holds two degrees in Biology (BS) and Biochemistry (BA) from Northern Kentucky University.
“DSI is an outstanding company with a great reputation for providing emerging and mid-sized pharmaceutical and biotechnology companies a comprehensive array of support services across, virtually, all regulated therapeutic dosage forms,” said Rob Rigney. “I am excited to join DSI’s executive leadership team and glad to, once again, be in a position to be a valuable resource for my clients. I am looking forward to using my experience and industry relationships to deliver DSI’s innovative end-to-end development services to the company’s network of customers.”
About Design Space InPharmatics
Design Space InPharmatics (DSI) is a full-service CMC consulting firm providing comprehensive regulatory, product development, and quality systems services to emerging and mid-size pharmaceutical and biopharmaceutical companies. Utilizing dedicated multi-disciplinary teams of experts, DSI supports customer needs in quality management, regulatory affairs, product manufacturing, testing, statistics, GMP, GCP and regulatory compliance. Additionally, DSI’s extensive experience spans all regulated therapeutic dosage forms serving more than 100 companies globally. For additional information about DSI and our broad range of services, please visit http://www.dsinpharmatics.com. “
Media Contact
Contact: Stephanie N. Kuhla
CEO | Creative Director
Email: skuhla@advantadna.com
Telephone: 847-ADVANTA
Website: www.advantadna.com
Media Contact:Edward Narke, Design Space InPharmatics (DSI), 855-805-8402, solutions@dsinpharmatics.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE Design Space InPharmatics (DSI)
